Do immune cells promote the pathology of dystrophin-deficient myopathies?

Neuromuscular Disorders

Volumn 11, Issue 6-7, 2001, Pages 556-564

  Spencer, Melissa J ^a,b   Tidball, James G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dystrophin deficient myopathies; Immune cells; Pathology

Indexed keywords

CYTOKINE; DYSTROPHIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UTROPHIN;

BONE MARROW CELL; CLINICAL FEATURE; COMPLEMENT ACTIVATION; CYTOTOXICITY; HUMAN; IMMUNOCOMPETENT CELL; MUSCLE DISEASE; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; MYOFIBROSIS; MYOSITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0034883653     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(01)00198-5     Document Type: Article

References (73)

1. Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber
2. Cloning of the Duchenne/Becker muscular dystrophy locus
3. Monoclonal antibody analysis of mononuclear cells in myopathies I
4. Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy
5. Muscle sarcomere lesions and thrombosis after spaceflight and suspension unloading
6. Acute phase response in exercise. III. Neutrophil and IL-1 beta accumulation in skeletal muscle
7. Macrophage invasion does not contribute to muscle membrane injury during inflammation
8. Immunohistochemical characterization of the mononuclear cells infiltrating muscle of patients with inflammatory and noninflammatory myopathies
9. Monoclonal antibody analysis of mononuclear cells in myopathies III
10. Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity
11. Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies
12. Helper (CD4+) and cytotoxic (CD8+) T cells promote the pathology of dystrophin-deficient muscle
13. Specific T cell receptor gene rearrangements at the site of muscle degeneration in Duchenne muscular dystrophy
14. The alpha beta T-cell receptor repertoire in inclusion body myositis: diverse patterns of gene expression by muscle-infiltrating lymphocytes
15. Predominant TCR-alpha beta variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies
16. Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. Restricted V alpha/beta rearrangements may indicate antigen-driven selection
17. X chromosome-linked muscular dystrophy (mdx) in the mouse
18. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs
19. Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors
20. Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells
21. Upregulation of Fas/Fas ligand in inclusion body myositis
22. The inhibition of apoptosis in myositis and in normal muscle cells
23. T-Cell-dependent fibrosis in the mdx dystrophic mouse
24. Induction of primary immune responses by allogeneic human myoblasts: dissection of the cell types required for proliferation, IFNgamma secretion and cytotoxicity
25. Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls
26. Cytokine expression profile in idiopathic inflammatory myopathies
27. Localization of interferons and interleukin 2 in polymyositis and muscular dystrophy
28. Altered pathological progression of diaphragm and quadriceps muscle in TNF-deficient, dystrophin-deficient mice
29. Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN-gamma (see comments)
30. Interferon gamma inhibits proliferation, differentiation, and creatine kinase activity of cultured human muscle cells. II. A possible role in myositis
31. Synergistic cytotoxic effect of interferon-gamma and tumor necrosis factor-alpha on cultured human muscle cells
32. Necrotizing myopathy induced by overexpression of interferon-gamma in transgenic mice
33. The predominance of beta (CC) chemokine transcripts in idiopathic inflammatory muscle diseases
34. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine (see comments)
35. Transforming growth factor-beta2 is elevated in skeletal muscle disorders
36. A quantitative test to detect lymphocytes sensitized against the surface of muscle cells
37. Lysis of myotubes by alloreactive cytotoxic T cells and natural killer cells: relevance to myoblast transplantation
38. Muscle regeneration and cell-mediated cytotoxicity in the autologous muscle culture of dermatomyositis
39. In vitro destruction of skeletal muscle by sensitized cells
40. Destruction of differentiated muscle cultures by sensitised lymphoid cells
41. Destruction of muscle cultures by lymphocytes from cases of polymyositis
42. Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies
43. Expression of class I and class II MHC antigens in neuromuscular diseases
44. Increased expression of the HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders
45. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles
46. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and t cell-mediated cytotoxicity in myopathies
47. Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions
48. Cell-mediated immune response after vasectomy in rats
49. Identification of cardiac autoantigens in human heart cDNA libraries using acute rheumatic fever sera
50. Autoreactivity to the cardiac myocyte, connective tissue and the extracellular matrix in heart disease and postcardiac injury
51. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and Western blotting
52. T cells in cardiac myosin-induced myocarditis
53. The role of myofibrillar fraction of skeletal muscle in the production of experimental polymyositis
54. Macrophage migration inhibition studies of lymphocytes taken from guinea-pigs suffering from experimental polymyositis
55. Lymphocyte sensitivity to skeletal muscle in patients with polymyositis and other disorders
56. Experimental myositis in rats. I. Histological and creatine phosphokinase changes, and passive transfer to normal syngeneic rats
57. Experimental myositis: the in-vivo and in-vitro activity of lymph-node cells
58. Immunocytochemical localisation of complement components C8 and C9 in human diseased muscle. The role of complement in muscle fibre damage
59. Complement activation in muscle fiber necrosis: demonstration of the membrane attack complex of complement in necrotic fibers
60. Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies
61. Complement activation promotes muscle inflammation during modified muscle use
62. Monoclonal antibody analysis of mononuclear cells in myopathies IV. Cell-mediated cytotoxicity and muscle fiber necrosis
63. Stages in fibre breakdown in Duchenne muscular dystrophy. An electron-microscopic study
64. A role for mast cells in the progression of Duchenne muscular dystrophy? Correlations in dystrophin-deficient humans, dogs, and mice
65. 2+ metabolism
66. Techniques for studying free radical damage in muscular dystrophy
67. Superoxide dismutases, glutathione peroxidase, and catalase in neuromuscular disease
68. Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state
69. Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy
70. Muscle cells from mdx mice have an increased susceptibility to oxidative stress
71. Duchenne-like myopathy in double-mutant mdx mice expressing exaggerated mast cell activity
72. Cromolyn increases strength in exercised mdx mice
73. Dystrophin-deficient myofibers are vulnerable to mast cell granule-induced necrosis